ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 820

Diurnal Stability of Transcriptional Profiles in Rheumatoid Arthritis

Louise Bennett1, Fraser Morton 1, George Fragoulis 1, Caron Paterson 1, Dominic Rimmer 2, Gary Semple 3, Alison Young 3, Jagtar S Nijjar 4, Michael Barrett 5, Stefan Siebert 1, Duncan Porter 5, Carl Goodyear 6 and Iain McInnes 1, 1Institute of Infection, Immunity & Inflammation, University of Glasgow, Glasgow, United Kingdom, 2Clinical Research Facility, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom, 3Clinical Research Facility, NHS Greater Glasgow and Clyde, Glasgow, 4Department of Medicine, University of Cambridge, Cambridge, United Kingdom, 5Institute of Infection, Immunity & Inflammation, University of Glasgow, Glasgow, 6University of Glasgow, Glasgow, United Kingdom

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: clinical research and RNA, Rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: 3S079: RA – Etiology & Pathogenesis I (815–820)

Session Type: ACR Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Our understanding of disease pathogenesis in Rheumatoid Arthritis (RA) is rapidly expanding with the advent of ‘Omics’ techniques. Importantly, current analysis takes into account many clinical covariates such as gender and age, however there are no studies to date that have systematically examined the impact that the timing of sample acquisition has on transcriptional profiles. This is a fundamental covariate given the real-world clinical setting of samples acquisition. Moreover, within day variation in RA symptoms are characteristic of disease (e.g. early morning stiffness). Herein, we evaluated the diurnal variation in transcriptomic profiles in 10 RA patients.

Methods: Whole blood was drawn into Paxgene tubes from 10 RA patients over the course of one day (8am, 9am, 11am, 1pm and 3pm), and stored at -80°C. RNA was extracted using the Paxgene Blood miRNA kit and libraries prepared for RNA-Seq using the Illumina TruSeq Stranded Total RNA Ribo-Zero H/M/R Gold kit. RNA-seq was performed and data analysed using the likelihood ratio test in the DESeq2 R package to identify any genes that showed a change in expression across the different time points. The genes identified as being differentially expressed and having a fold change greater than 1.5 between any two time points in the RNA-Seq analysis were clustered to identify patterns of expression. Gene ontology enrichment analysis as well as pathway over-representation analysis using the Reactome database was performed.

Results: RNA-Seq analysis identified 395 genes with a fold change of 1.5 or greater that were differentially expressed between the timepoints. Cluster analysis of these genes identified four patterns of expression. Two of the expression clusters (utilising 86 or 149 genes respectively) showed a decrease in transcripts throughout the day, figure 1. Notably,  the gene ontology terms associated with the clusters were; neutrophil activation, myeloid and leucocyte migration, neutrophil degranulation, figure 2a. Furthermore, Reactome Pathways Analysis highlighted; interleukin-33 signalling, interleukin-10 signalling, and interleukin-1 family signalling as over-representated in the clusters. All of which are commensurate with increased immune activation in the morning. In comparison, the other two expression clusters (utilising 29 and 65 gene respectively) increased during the day, figure 1. These clusters were associated with DNA replication and processing pathways and gene ontology terms, figure 2b.

Conclusion: Our results clearly demonstrate that timing of sample collection has a significant impact on the transcription profile of circulating cells and should therefore be accommodated within biomarker studies. Moreover, alterations were observed across rather fundamental biological pathways that may inform disease pathogenesis studies in future.


ARC abstarct Figure 1

Figure 1: Clustering of genes with similar expressions patterns – The figure shows the detected patterns of expression within the differentially expressed genes having a fold change greater than 1.5. The z-score of gene abundance represents the number of standard deviations the expression at a time point is away from the overall mean.


ACR Abstract figure 2

Figures 2a and 2b show the relationships between the genes from the cluster analysis and the enriched categories from the gene ontology analysis. Figure 2a show the genes from clusters 2 and 3 where there is an association with immune system function, and figure 2b, containing the genes from clusters 4 and 5, which were associated with DNA replication and processing. The fold changes displayed are log2 transformed and are between the 8am and 3pm time points.


Disclosure: L. Bennett, None; F. Morton, None; G. Fragoulis, None; C. Paterson, None; D. Rimmer, None; G. Semple, None; A. Young, None; J. Nijjar, None; M. Barrett, None; S. Siebert, Abbvie, 2, 5, 8, AbbVie, 2, 5, BMS, 2, Boehringer Ingelheim, 2, 5, 8, Celgene, 2, 5, 8, Janssen, 2, 5, 8, Novartis, 2, 5, 8, Pfizer, 2, 5, 8, UCB, 2, 5, 8; D. Porter, None; C. Goodyear, Celgene, 2, AstraZeneca, 2, 5, MedAnnex, 2, 5, UCB, 2, Jannsen, 2; I. McInnes, Abbott, Bristol-Myers Squibb, Merck Sharp & Dohme, Pfizer, Roche., 2, 8, Abbvie, 5, AbbVie, 2, 5, 8, Amgen, 2, 5, 8, Astra Zeneca, 2, 5, AstraZeneca, 5, BI, 2, 5, BMS, 2, 5, 8, Boehringer Ingelheim, 5, Celgene, 2, 5, 8, Eli Lilly, 2, 5, 8, Janssen, 2, 5, 8, Leo, 5, Lilly, 5, Novartis, 2, 5, 8, Pfizer, 2, 5, 8, UCB, 2, 5, 8.

To cite this abstract in AMA style:

Bennett L, Morton F, Fragoulis G, Paterson C, Rimmer D, Semple G, Young A, Nijjar J, Barrett M, Siebert S, Porter D, Goodyear C, McInnes I. Diurnal Stability of Transcriptional Profiles in Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/diurnal-stability-of-transcriptional-profiles-in-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/diurnal-stability-of-transcriptional-profiles-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology